Clinical and pathological influencing factors for breast cancer recurrence and metastasis after mastectomy

唐鹏; 姜军; 杨新华; 范林军; 张毅; 张帆; 钟玲

您当前的位置：

首页 >

文章列表页 >

Clinical and pathological influencing factors for breast cancer recurrence and metastasis after mastectomy

更新时间：2026-01-09

- Clinical and pathological influencing factors for breast cancer recurrence and metastasis after mastectomy
- Journal of Army Medical University Vol. 29, Issue 11, Pages: 1099-1101(2007)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：
  CLC： R73-37;R730.2;R737.9
- Published：2007
- 稿件说明：
移动端阅览
唐鹏,姜军,杨新华,范林军,张毅,张帆,钟玲.影响乳腺癌改良根治术后复发转移的临床病理因素分析[J].陆军军医大学学报(原第三军医大学学报),2007,29(11):1099-1101.

　TANG Peng,JIANG Jun,YANG Xin-hua,FAN Lin-jun,ZHANG Yi,ZHANG Fan,ZHONG Ling.Clinical and pathological influencing factors for breast cancer recurrence and metastasis after mastectomy[J].J Amry Med Univ (J Third Mil Med Univ),2007,29(11):1099-1101.
唐鹏,姜军,杨新华,范林军,张毅,张帆,钟玲.影响乳腺癌改良根治术后复发转移的临床病理因素分析[J].陆军军医大学学报(原第三军医大学学报),2007,29(11):1099-1101. DOI：

　TANG Peng,JIANG Jun,YANG Xin-hua,FAN Lin-jun,ZHANG Yi,ZHANG Fan,ZHONG Ling.Clinical and pathological influencing factors for breast cancer recurrence and metastasis after mastectomy[J].J Amry Med Univ (J Third Mil Med Univ),2007,29(11):1099-1101. DOI：

摘要

目的探讨影响乳腺癌术后局部复发与远处转移的临床病理因素。方法对比分析我院1997年5月至2005年8月收治的女性乳腺癌初治病例中术后5年内复发转移患者与5年以上无复发生存患者的临床病理资料。结果患者年龄、肿瘤组织病理类型、肿瘤大小、淋巴结转移情况、激素受体状态以及辅助化疗和内分泌治疗情况是影响乳腺癌术后复发转移的重要因素。结论乳腺癌早期诊断和规范化治疗是降低乳腺癌术后复发转移，提高生存率的关键。

Abstract

Objective To discuss the clinical and pathological factors which influence breast cancer recurrence and metastasis after mastectomy. Methods The clinical and pathological data of the breast cancer patients

who underwent mastectomy in our hospital between May 1997 and August 2005

was collected. The differences between the patients whose diseases recurred and/or metastasized in 5 years after mastectomy and those who survived free of the disease more than 5 years were analyzed. Results Age

pathological type

tumor size

lymph node status

hormone receptor status adjuvant chemotherapy and endocrinotherapy were the important influencing factors. Conclusion Early diagnosis and standard therapy are key to degrade the rate of breast cancer recurrence and metastasis after mastectomy.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Sulfasalazine antagonizes boosted metastasis of breast cancer induced by ionizing radiation

A novel estrogen receptor expression stratification (low/moderate/high) based on Chinese population provides more accurate prognosis prediction for HR⁺/HER2^- early breast cancer patients

Value of MRI radiomics based on intratumoral and peritumoral heterogeneity in predicting spatial patterns of locally recurrent high-grade gliomas

Value of DCE-MRI parameters for short-term prognosis of pharyngeal cancer after postoperative radiotherapy

Development and validation of clinical prediction model for post-treatment recurrence in high-risk non-muscle invasive bladder cancer after BCG intravesical instillation

Related Author

Ge HE

Guojian WANG

Na ZHAO

Shuang LONG

Tao WANG

Jia MING

WANG Chengfang

ZHOU Yuqin

Related Institution

Department of Breast and Thyroid Surgery, the Second Affiliated Hospital of Chongqing Medical University

State Key Laboratory of Trauma, Burns and Combined Injury, Department of Anti-Radiation Medicine, Chongqing Engineering Research Center for Nanomedicine, Institute of Combined Injury, Faculty of Military Preventive Medicine, Army Medical University (Third Military Medical University)

Department of Breast and Thyroid Surgery， First Affiliated Hospital， Army Medical University （Third Military Medical University）

Department of Radiology， Chongqing Clinical Research Centre of Imaging and Nuclear Medicine, Faculty of Biomedical Engineering and Imaging Medicine， Army Medical University （Third Military Medical University）

Department of Neurosurgery， Army Medical Center of PLA/Daping Hospital of Third Military Medical University， Chongqing, Faculty of Biomedical Engineering and Imaging Medicine， Army Medical University （Third Military Medical University）

⁰